Treatment of Pelvic Ring Fractures in the Elderly
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Oct 27, 2015
Trial Information
Current as of June 06, 2025
Terminated
Keywords
ClinConnect Summary
Comparison of surgical vs conservative treatment with respect to mobility, pain, morbidity and mortality.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • CTI/MRI verified fracture of the sacrum affecting the posterior ring or both posterior and anterior ring
- • age\>65 years, ambulatory with/without walking aids before Trauma
- • ambulatory with/without walking aids before trauma
- • postmenopausal status in women
- • informed consent for study participation and surgery
- Exclusion Criteria:
- • Refusal of consent by the patient or legal representatives to participate in the study
- • Other fractures or
- • Unstable pelvic fracture (type B or C according to classification of 'Arbeitsgemeinschaft für Osteosynthesefragen' (AO)/OTA) requiring surgical stabilisation after high- or low-energy trauma
- • Suspicion of a pathological fracture in the context of known or unknown malignancy
- • Previous surgery of the pelvis with metal obstructing the planned paths of the ilio-sacral screws
- • Symptomatic low back pain with morphological changes, i.e. intervertebral disc displacement, neoplasm metastasis in the axial skeleton, spinal stenosis, vertebral fracture, spondylarthropathy etc.
- • Comorbidity that precludes undergoing general or spinal anaesthesia
- • Pre-trauma mobility status that precludes achieving a post-trauma mobility status enabling the patient to perform the timed up and go test (e.g. patient being in a wheel chair)
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Basel, Basel Stadt, Switzerland
Patients applied
Trial Officials
Marcel Jakob, Prof
Study Director
University Hospital, Basel, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials